Can Breast Cancer Be Prevented? Dr. Steven Quay Featured on CEO Talks

Dr. Steven Quay, MD, PhD, CEO of Atossa Therapeutics, was recently featured on the CEO Talks series hosted by Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine.

In this interview, Dr. Quay explains Atossa’s pioneering work to move breast cancer care beyond treatment into prevention. Key topics include:

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content